Tirzepatide (Tirz) is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist developed for research into glucose regulation, weight management, and metabolic health. Its unique dual-action mechanism enhances insulin secretion, improves insulin sensitivity, and promotes appetite suppression, making it a powerful tool in metabolic research.

Research Applications & Potential Effects:

• Studies on blood glucose regulation and insulin sensitivity

• Research into weight reduction and appetite suppression

• Investigations of dual incretin pathways for metabolic health

• Preclinical evaluation of cardiovascular and lipid profile changes

Supplied as a sterile, lyophilised powder in liquid to ensure maximum purity and stability for precise experimental outcomes.

Molecular Formula: C225H348N48O68
Molar Mass: 4813.52 g/mol
Form: Lyophilised powder in liquid
Purity: ≥ 99% (HPLC)
Storage: Store at −20 °C, protect from light
Intended Use: Strictly for research purposes only. Not for human consumption, medical, or veterinary use.
CAS Number: 2023788-19-2